Terms: = Ovarian cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721
841 results:
1. Circular RNA circMAN1A2 promotes ovarian cancer progression through the microRNA-135a-3p/IL1RAP/TAK1 pathway.
Li B; Hu C; Zhao D; Nie M; Wang X
PeerJ; 2024; 12():e16967. PubMed ID: 38680890
[TBL] [Abstract] [Full Text] [Related]
2. Ginger inhibits the invasion of ovarian cancer cells SKOV3 through CLDN7, CLDN11 and CD274 m6A methylation modifications.
Zhang X; Zhang H; Zhu L; Xia L
BMC Complement Med Ther; 2024 Apr; 24(1):145. PubMed ID: 38575994
[TBL] [Abstract] [Full Text] [Related]
3. [Preparation and characterization of chicken anti-human B7-H4 IgY polyclonal antibody].
Zhang L; Fan Z; Zhang W; Huang H; Wang J; Hei A; Cong Y; Xu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):257-266. PubMed ID: 38512036
[TBL] [Abstract] [Full Text] [Related]
4. Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2.
Liu F; Zhang Y; Xia X; Han J; Cao L
J Obstet Gynaecol Res; 2024 May; 50(5):864-872. PubMed ID: 38480480
[TBL] [Abstract] [Full Text] [Related]
5. HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells.
Kou X; Yang X; Zhao Z; Li L
Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):356-365. PubMed ID: 38419499
[TBL] [Abstract] [Full Text] [Related]
6. ZSWIM4 inhibition improves chemosensitivity in epithelial ovarian cancer cells by suppressing intracellular glycine biosynthesis.
Gong K; Huang Y; Zheng Y; Hao W; Shi K
J Transl Med; 2024 Feb; 22(1):192. PubMed ID: 38383406
[TBL] [Abstract] [Full Text] [Related]
7. Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer.
Lv J; Zhang Y; Yang M; Qiao L; Wang H; Jiang H; Fu M; Qin J; Xu S
Cancer Gene Ther; 2024 Jan; 31(1):108-118. PubMed ID: 38102461
[TBL] [Abstract] [Full Text] [Related]
8. 8-hydroxyquinoline-N-oxide copper(II)- and zinc(II)-phenanthroline and bipyridine coordination compounds: Design, synthesis, structures, and antitumor evaluation.
Du LQ; Zeng CJ; Mo DY; Qin QP; Tan MX; Liang H
J Inorg Biochem; 2024 Feb; 251():112443. PubMed ID: 38100902
[TBL] [Abstract] [Full Text] [Related]
9. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
[TBL] [Abstract] [Full Text] [Related]
10. RNF144B-mediated p21 degradation regulated by HDAC3 contribute to enhancing ovarian cancer growth and metastasis.
Zhuang H; Zhang Z; Wang W; Qu H
Tissue Cell; 2024 Feb; 86():102277. PubMed ID: 37992458
[TBL] [Abstract] [Full Text] [Related]
11. The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis.
Liu Y; Li Y; Wu Y; Zhao Y; Hu X; Sun C
J Ovarian Res; 2023 Nov; 16(1):219. PubMed ID: 37986114
[TBL] [Abstract] [Full Text] [Related]
12. CircCDK17 promotes the proliferation and metastasis of ovarian cancer cells by sponging miR-22-3p to regulate CD147 expression.
Qu B; Sun L; Xiao P; Shen H; Ren Y; Zhang J
Carcinogenesis; 2024 Feb; 45(1-2):83-94. PubMed ID: 37952105
[TBL] [Abstract] [Full Text] [Related]
13. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
14. Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis.
Wang H; Li Y; Wang Y; Shang X; Yan Z; Li S; Bao W
J Gynecol Oncol; 2024 Mar; 35(2):e13. PubMed ID: 37921598
[TBL] [Abstract] [Full Text] [Related]
15. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
Song Y; Li L; Xi Y
Tissue Cell; 2023 Dec; 85():102253. PubMed ID: 37890327
[TBL] [Abstract] [Full Text] [Related]
16. Effect of alpha lipoic acid on epithelial mesenchymal transition in SKOV-3 cells.
Önder E; Çil N; Seçme M; Mete GA
Gene; 2024 Jan; 892():147880. PubMed ID: 37813206
[TBL] [Abstract] [Full Text] [Related]
17. Biological function of C-X-C Motif Chemokine Ligand 1 gene (CXCL1) in ovarian malignant tumors.
Li Z; Huang N; Zhang W; Li L
Hum Exp Toxicol; 2023; 42():9603271231203392. PubMed ID: 37787042
[TBL] [Abstract] [Full Text] [Related]
18. Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies.
Li H; Wang Y; Li G; Xiong J; Qin L; Wen Q; Yue C
J Gene Med; 2024 Jan; 26(1):e3600. PubMed ID: 37776237
[TBL] [Abstract] [Full Text] [Related]
19. Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer.
Sheng B; Zhao B; Dong Y; Zhang J; Wu S; Ji H; Zhu X
Carcinogenesis; 2023 Dec; 44(10-11):748-759. PubMed ID: 37747823
[TBL] [Abstract] [Full Text] [Related]
20. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.
Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
[TBL] [Abstract] [Full Text] [Related]
[Next]
